Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

571 Views

I1. Adult Vaccines

Poster Session: Adult Vaccines

(P-8) Assessment of 13-valent pneumococcal conjugate vaccine effectiveness among people living with HIV in the United States

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Amanda C. Miles, MPH (she/her/hers)

Senior Manager, RWE Scientist, Vaccines
Pfizer
New York, New York, United States

Co-Author(s)

SW

Sarah J. Willis, PhD, MPH

Director, Vaccines RWE Scientist
Pfizer
Wakefield, Massachusetts, United States
EC

Erica Chilson, PharmD

Senior Director, US Medical Affairs
Pfizer
500 Arcola Road, Pennsylvania, United States
LG

Lindsay Grant, PhD, MPH

Pfizer Inc.
New York, New York, United States
CT

Christian Theilacker, MD, DTM&H

Pfizer Inc.
New York, New York, United States
CH

Cassandra Hall-Murray, PharmD

Senior Director, Vaccines Medical Development and Scientific Affairs
Pfizer, Inc.
Collegeville, Pennsylvania, United States
QY

Qi Yan, PhD, MS

Pfizer Inc.
New York, New York, United States
JV

Jeffrey T. Vietri, PhD

Director, HEOR
Pfizer, Inc.
Collegeville, Pennsylvania, United States
TA

Tamuno Alfred, PhD

Pfizer
New York City, New York, United States
AC

Alejandro D. Cane, MD, PhD

North America Vaccines Medical Scientific Affairs Lead
Pfizer
Collegeville, Pennsylvania, United States
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States